实体器官移植项目在COVID-19大流行中面临缺乏经验性证据:一项旁证学会推荐共识方法
该研究针对COVID-19大流行中实体器官移植面临缺乏科学证据的关键问题,从22个移植学会的个体信息中提取关键推荐并计算不同组织间的共识程度。结果显示,各学会对临时暂停非紧急移植手术和活体捐献项目存在高度共识,并广泛推荐对供者和受者进行系统性聚合酶链反应检测。分析还纳入了更具体的方面(如手术摘取团队的筛查和边缘供者器官的限制使用)。该研究提供了一种在缺乏先验科学证据时为医疗管理提供知情指导的新方法。
要点
- 基于22个移植学会信息的共识分析显示,对临时暂停非紧急移植手术和活体捐献项目存在高度共识。
- 广泛推荐对供者和受者进行系统性聚合酶链反应检测。
- 分析纳入更具体方面,如手术摘取团队的筛查和边缘供者器官的限制使用。
- 移植医师在COVID-19大流行中面临科学证据的完全缺乏,该研究提供共识导向方法。
适用人群与场景
- 实体器官移植项目,涉及供者、受者及移植医师;场景为COVID-19大流行期间医疗资源受限环境。
处置流程与药物剂量
- 临时暂停非紧急移植手术和活体捐献项目(高度共识)。
- 对供者和受者进行系统性聚合酶链反应检测(广泛推荐)。
- 纳入手术摘取团队的筛查和边缘供者器官的限制使用等具体方面。
研究设计与关键结果
- 研究从22个移植学会的个体信息中提取关键推荐并计算不同组织间的共识程度,发现对临时暂停非紧急移植手术和活体捐献项目存在高度共识,广泛推荐对供者和受者进行系统性聚合酶链反应检测,分析还纳入手术摘取团队筛查和边缘供者器官限制使用等具体方面。
证据类型、等级与局限
- 证据类型:基于22个移植学会信息的共识分析(旁证学会推荐共识方法)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在COVID-19大流行期间,移植医师面临科学证据完全缺乏,该共识方法可为医疗管理提供知情指导;各学会高度共识建议临时暂停非紧急移植手术和活体捐献项目,并广泛推荐对供者和受者进行系统性聚合酶链反应检测。
指南或共识出处
- 原文引用22个移植学会的信息,未列出具体指南名称。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
The ongoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has a drastic impact on national health care systems. Given the overwhelming demand on facility capacity, the impact on all health care sectors has to be addressed. Solid organ transplantation represents a field with a high demand on staff, intensive care units, and follow-up facilities. The great therapeutic value of organ transplantation has to be weighed against mandatory constraints of health care capacities. In addition, the management of immunosuppressed recipients has to be reassessed during the ongoing coronavirus disease 2019 (COVID-19) pandemic. In addressing these crucial questions, transplant physicians are facing a total lack of scientific evidence. Therefore, the aim of this study was to offer an approach of consensus-based guidance, derived from individual information of 22 transplant societies. Key recommendations were extracted and the degree of consensus among different organizations was calculated. A high degree of consensus was found for temporarily suspending nonurgent transplant procedures and living donation programs. Systematic polymerase chain reaction-based testing of donors and recipients was broadly recommended. Additionally, more specific aspects (eg, screening of surgical explant teams and restricted use of marginal donor organs) were included in our analysis. This study offers a novel approach to informed guidance for health care management when a priori no scientific evidence is available.
参考来源
- Ritschl PV, Nevermann N, Wiering L, et al. Solid organ transplantation programs facing lack of empiric evidence in the COVID-19 pandemic: A By-proxy Society Recommendation Consensus approach. Am J Transplant. 2020. PMID: 32323460. doi:10.1111/ajt.15933
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。